Solta Medical, Inc. Raises FY 2012 Revenue Guidance; Reaffirms Quarterly, FY 2012 EBITDA Guidance

Solta Medical, Inc. announced that for fiscal 2012, it expects revenue be in the range of $142 million to $144 million from the previously provided revenue outlook of $140 million to $143 million. The outlook for positive non-GAAP EBITDA for every quarter and for fiscal 2012 remains unchanged. According to I/B/E/S Estimates, analysts were expecting the Company to report revenues of $144 million and EBITDA of $15 million for fiscal 2012; EBITDA of $3.5 million for the third quarter of 2012; EBITDA of $6.6 million for the fourth quarter of 2012.